top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

20 Oktoba 2026, 12:37:49

Systemic lupus erythematosus (SLE) and neonatal lupus

Systemic lupus erythematosus (SLE) and neonatal lupus

20 Oktoba 2026, 12:37:49

  • Fever, fatigue, weight loss, arthritis, malar or discoid rash, photosensitivity, nephritis, seizures or psychosis, pleurisy, ILD, pericarditis, anaemia, leukopenia, thrombocytopenia.

  • Investigations: CBC, ESR/CRP, ANA, anti-dsDNA, anti-Sm, antiphospholipid antibodies, anti-Ro/La/U1 RNP, urinalysis and creatinine, C3/C4, renal biopsy for nephritis, chest X-ray, echo, abdominal ultrasound.

Management

  • Sun protection (SPF 50 or more), education, vaccination (pneumococcal, influenza), monitor BP, renal, blood and cardiovascular risk.

  • All patients: S: hydroxychloroquine 200–400 mg once daily (5 mg/kg/day, maximum 400 mg).

  • Mild musculoskeletal pain or serositis: NSAIDs (e.g. diclofenac 50 mg 2–3 times daily, meloxicam 7.5–15 mg daily).

Steroid dose

Regimen

Use

Low

A: Prednisolone up to 7.5 mg/day

Mild disease (skin, joints)

Moderate

A: Prednisolone 10–30 mg/day

Serositis, cytopenia

High / pulse

A: Prednisolone 1–2 mg/kg/day; D: methylprednisolone 500–1000 mg/day for 3 days

Nephritis, CNS lupus, severe cytopenias, myocarditis, alveolar haemorrhage

Indication

Immunosuppressant

Moderate disease; lupus nephritis maintenance

S: Azathioprine 1–2 mg/kg/day

Arthritis, skin disease

S: Methotrexate 15–25 mg/week

Lupus nephritis III/IV/V, pneumonitis, vasculitic ulcers, cytopenias

S: Mycophenolate mofetil – induction 2–3 g/day, maintenance 1–2 g/day

Severe organ involvement (renal, CNS, cardiac)

S: Cyclophosphamide 500–1000 mg/m² monthly × 6, then MMF or azathioprine

Refractory or severe

S: Rituximab IV 1000 mg × 2 doses, 2 weeks apart

  • Adjuncts: low-dose aspirin with antiphospholipid antibodies; ACE inhibitor/ARB for proteinuria; statins; calcium/vitamin D and bisphosphonate on long-term steroids; co-trimoxazole PJP prophylaxis on high-dose steroids or cyclophosphamide.

Neonatal lupus

  • From maternal anti-Ro/SSA, anti-La/SSB (or anti-U1 RNP) antibodies; mother may have SLE or Sjögren's or be asymptomatic.

  • Annular/periorbital rash (resolves by 6–8 months), photosensitivity, congenital heart block (often permanent), hepatitis, cytopenias. Check ECG, CBC, LFTs, anti-Ro/La.

  • Sun protection and mild topical steroid for rash; pacemaker for severe heart block; in later pregnancies hydroxychloroquine and fetal echocardiography at 16–26 weeks.

Imeandikwa:

20 Oktoba 2026, 12:37:49

bottom of page